Dr. Roberto Plebani is an Assistant Professor at the Department of Medical, Oral, and Biotechnological Sciences, University G. d’Annunzio of Chieti-Pescara.The main topic of his research is studying inflammation cystic fibrosis (CF), focusing on immune cell migration experiments using three-dimensional in vitro culture models.He recently spent over one year (2020 – 2021) at the Wyss Institute (Harvard, Boston, MA, USA) to learn the organ-on-chip technology and model the first CF airway-chip, composed of a CF pseudostratified human bronchial epithelium and a microvascular endothelium, interacting with neutrophils and bacteria, aimed to the study of inflammation in CF. During that period, he took part on studies on respiratory viruses using lung-chips, and on the modeling on-chip of a vaginal tissue. He has been invited to return to Harvard in 2022 to train a team of a microbiology lab at the Mass General Hospital to culture and infect the airway-chip with the pathogen Pseudomonas aeruginosa and further optimize the infection conditions.He is currently working on a project - in collaboration with a former colleague at the Wyss Institute - funded by the Italian Cystic Fibrosis Foundation (CFF), in the perspective of constructing a “full CF” lung airway-on-a-chip, which will also include CF endothelial cells and fibroblasts.
Dr. Roberto Plebani is an Assistant Professor at the Department of Medical, Oral, and Biotechnological Sciences, University G. d’Annunzio of Chieti-Pescara.The main topic of his research is studying inflammation cystic fibrosis (CF), focusing on immune cell migration experiments using three-dimensional in vitro culture models.He recently spent over one year (2020 – 2021) at the Wyss Institute (Harvard, Boston, MA, USA) to learn the organ-on-chip technology and model the first CF airway-chip, composed of a CF pseudostratified human bronchial epithelium and a microvascular endothelium, interacting with neutrophils and bacteria, aimed to the study of inflammation in CF. During that period, he took part on studies on respiratory viruses using lung-chips, and on the modeling on-chip of a vaginal tissue. He has been invited to return to Harvard in 2022 to train a team of a microbiology lab at the Mass General Hospital to culture and infect the airway-chip with the pathogen Pseudomonas aeruginosa and further optimize the infection conditions.He is currently working on a project - in collaboration with a former colleague at the Wyss Institute - funded by the Italian Cystic Fibrosis Foundation (CFF), in the perspective of constructing a “full CF” lung airway-on-a-chip, which will also include CF endothelial cells and fibroblasts.